COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic

Gülnihan Eren; Kadri Altundağ

Research Article

COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic

Year 2022, Volume: 12 Issue: 4, 105 - 110, 15.12.2022

Abstract

ÖZET
Amaç: Çalışmamızda karantina döneminde (KD) ve Karantina öncesi dönemde (KÖ) tanı alan meme kanseri
hastalarını klinik ve patolojik özellikler açısından karşılaştırmayı amaçladık.
Gereç ve Yöntemler: 23’ü karantina döneminde ve 47'si karantina öncesi dönemde olmak üzere toplam 70
hasta retrospektif olarak değerlendirildi. Menopoz durumu, semptom varlığı, ameliyatın türü, hormonal alt
gruplar, kemoterapinin amacı, T, N, M evreleri çapraz tablolar kullanılarak gruplara ayrıldı. Gruplar arasındaki
farklılıklar Ki-kare testleri kullanılarak karşılaştırıldı.
Bulgular: Çalışmamızda, KD hasta sayısı KÖ döneme göre daha azdı (23 vs. 47). Yaş, menopoz durumu, tedaviye
başlama zamanı, tarama oranı, hormonal alt tip, ameliyat tipi, T, N, M evresi gibi değişkenlerde anlamlı
bir fark bulunmadı. Ortanca tümör boyutu KD hastalarda 2,42 cm (0,3-0,65) KÖ hastalarda 2,37 cm (0,4-6)’di
(p= 0,796). KD 9 hastada (%39) lenf nodu metastazı saptanırken, KÖ 21 hastada (%45) lenf nodu metastazı
saptanmıştır (p= 0,784). Tanı anında KD 3 hastada (%13) uzak metastaz saptanırken, KÖ 6 hastada (%13) uzak
metastaz saptanmıştır (p= 0,542).
Sonuç: Karantina döneminde hasta sayısı karantina öncesi döneme göre daha azdı. Meme kanseri hastalarında
karantina süresi ile aynı dönemden bir yıl önceki zaman aralığı arasında klinik bir fark saptanmadı.
Anahtar Kelimeler: Covid-19; Karantina; Pandemi; Meme Kanseri

Keywords

COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA, PATOLOJİK VE KLİNİK ÖZELLİKLER, Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic

References

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323: 1239-42.
2. Buonomo OC, Materazzo M, Pellicciaro M, Caspi J, Piccione E, Vanni G. Tor Vergata University-Hospital in the beginning of COVID-19-Era: Experience and recommendation for breast cancer patients. In vivo. 2020;34:1661-5.
3. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med. 2020;172:756-8.
4. Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, et al. Management of cancer surgery cases during the COVID-19 pandemic: Considerations. Ann Surg Oncol. 2020;27(6):1717-20.
5. Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C, et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO open. 2020;5(2):e000759.
6. Cammalleri V, Muscoli S, Benedetto D, Stifano G, Macrini M, Di Landro A, et al. Who Has Seen Patients With ST‐Segment–Elevation Myocardial Infarction? First Results From Italian Real‐World Coronavirus Disease 2019. J Am Heart Assoc. 2020;9(19): e017126.
7. Curigliano G, Cardoso MJ, Poortmans P, Gentilini O, Pravettoni G, Mazzocco K, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52: 8-16.
8. Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo OC. Breast cancer diagnosis in Coronavirus-Era: alert from Italy. FrontOncol 2020;10:938.
9. Vanni G, Tazzioli G, Pellicciaro M, Materazzo M, Paolo O, Cattadori F, et al. Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients. Anticancer Res. 2020;40:7119-25.
10. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.

Year 2022, Volume: 12 Issue: 4, 105 - 110, 15.12.2022

Gülnihan Eren Kadri Altundağ

Abstract

Keywords

COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA, PATOLOJİK VE KLİNİK ÖZELLİKLER, Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic

References

1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323: 1239-42.
2. Buonomo OC, Materazzo M, Pellicciaro M, Caspi J, Piccione E, Vanni G. Tor Vergata University-Hospital in the beginning of COVID-19-Era: Experience and recommendation for breast cancer patients. In vivo. 2020;34:1661-5.
3. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med. 2020;172:756-8.
4. Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, et al. Management of cancer surgery cases during the COVID-19 pandemic: Considerations. Ann Surg Oncol. 2020;27(6):1717-20.
5. Lambertini M, Toss A, Passaro A, Criscitiello C, Cremolini C, Cardone C, et al. Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective. ESMO open. 2020;5(2):e000759.
6. Cammalleri V, Muscoli S, Benedetto D, Stifano G, Macrini M, Di Landro A, et al. Who Has Seen Patients With ST‐Segment–Elevation Myocardial Infarction? First Results From Italian Real‐World Coronavirus Disease 2019. J Am Heart Assoc. 2020;9(19): e017126.
7. Curigliano G, Cardoso MJ, Poortmans P, Gentilini O, Pravettoni G, Mazzocco K, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52: 8-16.
8. Vanni G, Pellicciaro M, Materazzo M, Palombi L, Buonomo OC. Breast cancer diagnosis in Coronavirus-Era: alert from Italy. FrontOncol 2020;10:938.
9. Vanni G, Tazzioli G, Pellicciaro M, Materazzo M, Paolo O, Cattadori F, et al. Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients. Anticancer Res. 2020;40:7119-25.
10. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.

There are 10 citations in total.

Details

Primary Language	Turkish
Subjects	Health Care Administration
Journal Section	Original Research
Authors	Gülnihan Eren This is me Kadri Altundağ This is me
Publication Date	December 15, 2022
Published in Issue	Year 2022 Volume: 12 Issue: 4

Cite

APA	Eren, G., & Altundağ, K. (2022). COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic. Bozok Tıp Dergisi, 12(4), 105-110.
AMA	Eren G, Altundağ K. COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic. Bozok Tıp Dergisi. December 2022;12(4):105-110.
Chicago	Eren, Gülnihan, and Kadri Altundağ. “COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic”. Bozok Tıp Dergisi 12, no. 4 (December 2022): 105-10.
EndNote	Eren G, Altundağ K (December 1, 2022) COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic. Bozok Tıp Dergisi 12 4 105–110.
IEEE	G. Eren and K. Altundağ, “COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic”, Bozok Tıp Dergisi, vol. 12, no. 4, pp. 105–110, 2022.
ISNAD	Eren, Gülnihan - Altundağ, Kadri. “COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic”. Bozok Tıp Dergisi 12/4 (December 2022), 105-110.
JAMA	Eren G, Altundağ K. COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic. Bozok Tıp Dergisi. 2022;12:105–110.
MLA	Eren, Gülnihan and Kadri Altundağ. “COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic”. Bozok Tıp Dergisi, vol. 12, no. 4, 2022, pp. 105-10.
Vancouver	Eren G, Altundağ K. COVID-19 PANDEMİSİNE BAĞLI KARANTİNA DÖNEMİNDE MEME KANSERİ HASTALARINDA PATOLOJİK VE KLİNİK ÖZELLİKLER Clinicopathologic Features of Breast Cancer Patients In The Lockdown Period Due To The Covid-19 Pandemic. Bozok Tıp Dergisi. 2022;12(4):105-10.